Table 2.
Univariate and multivariate predictive models of PRISMA-A items reported in abstracts of SRs on psoriasis interventions
| Univariable | Multivariable | ||||
|---|---|---|---|---|---|
| Variables | analysis | analysis | |||
| n | Estimate (SE) | p-value | Estimate (SE) | OR (95%CI) | |
| Abstract word count | |||||
| ≤ 300 | 98 | 1 | |||
| > 300 | 40 | 1.068(0.539) | 0.049 | 0.741(0.332) | 1.456(0.658-3.240) |
| Abstract format | |||||
| 8-headings | 16 | 1 | |||
| IMRAD | 77 | − 1.205(0.418) | 0.004 | − 0.049(0.418) | 0.951(0.420-2.153) |
| Free format | 45 | − 1.539(0.445) | < 0.001 | − 0.152(0.415) | 0.858(0.378-1.939) |
| Cochrane affiliation | |||||
| Yes | 9 | 1.068(0.539) | 0.049 | 0.543(0.734) | 1.722(0.401-7.296) |
| No | 129 | 1 | |||
| Number of authors | |||||
| ≤ 6 | 102 | 1 | |||
| > 6 | 36 | 0.600(0.303) | 0.049 | 0.725(0.341) | 1.098(1.012-1.194) |
| Conflict of interest | |||||
| ≤ 20% | 59 | 1 | |||
| > 20% | 61 | − 0.400(0.260) | 0.126 | ||
| Funding source | |||||
| Academic | 39 | 1.156(0.283) | < 0.001 | 1.247(0.428) | 3.630(1.788-7.542) |
| Pharmaceutical | 40 | − 0.198(0.297) | 0.506 | ||
| No funding/UNK | 59 | 0.302(0.478) | 0.528 | ||
| PRISMA endorser journal | |||||
| Yes | 10 | 1.562(0.448) | 0.002 | 2.016(0.698) | 4.370(1.785-10.98) |
| No | 117 | 1 | |||
| PRISMA-A statement | |||||
| Review published before | 71 | − 0.421(0.371) | 0.119 | ||
| Review published after | 68 | 1 | |||
| Journal impact factor | |||||
| ≤ 3 | 74 | 1 | |||
| > 3 | 43 | 0.331(0.373) | 0.014 | 0.331(0.373) | 1.392(0.669-2.912) |